BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32569884)

  • 1. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
    Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
    J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
    Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
    J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
    Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.
    Kohler L; Nease L; Vo P; Garofolo J; Heidary DK; Thummel RP; Glazer EC
    Inorg Chem; 2017 Oct; 56(20):12214-12223. PubMed ID: 28949518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy.
    Huang H; Yu B; Zhang P; Huang J; Chen Y; Gasser G; Ji L; Chao H
    Angew Chem Int Ed Engl; 2015 Nov; 54(47):14049-52. PubMed ID: 26447888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl-Substituted Ruthenium(II) Complexes: A Strategy for Enhanced Photocleavage and Efficient DNA Binding.
    Abreu FD; Paulo TF; Gehlen MH; Ando RA; Lopes LGF; Gondim ACS; Vasconcelos MA; Teixeira EH; Sousa EHS; de Carvalho IMM
    Inorg Chem; 2017 Aug; 56(15):9084-9096. PubMed ID: 28726387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
    Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y
    J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.
    Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G
    Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
    Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
    J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinoma.
    Casula L; Elena Giacomazzo G; Conti L; Fornasier M; Manca B; Schlich M; Sinico C; Rheinberger T; Wurm FR; Giorgi C; Murgia S
    J Colloid Interface Sci; 2024 Sep; 670():234-245. PubMed ID: 38761576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
    Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
    Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium(II) Polypyridyl Complexes as Photosensitizers for Antibacterial Photodynamic Therapy: A Structure-Activity Study on Clinical Bacterial Strains.
    Le Gall T; Lemercier G; Chevreux S; Tücking KS; Ravel J; Thétiot F; Jonas U; Schönherr H; Montier T
    ChemMedChem; 2018 Oct; 13(20):2229-2239. PubMed ID: 30157309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ru(II) polypyridyl complex bearing aldehyde functions as a versatile synthetic precursor for long-wavelength absorbing photodynamic therapy photosensitizers.
    Karges J; Heinemann F; Maschietto F; Patra M; Blacque O; Ciofini I; Spingler B; Gasser G
    Bioorg Med Chem; 2019 Jun; 27(12):2666-2675. PubMed ID: 31103403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
    Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
    Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Action Ru(II) Complexes with Bulky π-Expansive Ligands: Phototoxicity without DNA Intercalation.
    Toupin NP; Nadella S; Steinke SJ; Turro C; Kodanko JJ
    Inorg Chem; 2020 Mar; 59(6):3919-3933. PubMed ID: 32096986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.